IMBdx
461030.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$35.76B
Close$
Share Statistics
| Market cap | $35.76 Billion |
|---|---|
| Enterprise Value | $24.67 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-565.99 |
| Beta | 0.46 |
| Outstanding Shares | 14,334,517 |
Return
| Return on Equity | -32.55% |
|---|---|
| Return on Assets | -30.79% |
| Return on Invested Capital | -35.29% |
Valuation & Multiples
| P/E Ratio | -4.63 |
|---|---|
| PEG | 10.64 |
| Price to Sales | 6.4 |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | 4.41 |
| Enterprise Value to EBIT | -2.96 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About IMBdx
58 employees
CEO: Tae-You Kim IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-s...